NCT02301858View on ClinicalTrials.gov

Identification of Predictive and Prognostic Markers for Lung Cancer With Metastases

NAActive, not recruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Lung CancerPrimary TumorMetastases
Interventions
GENETIC

Genome analysis of tissue samples.

Genome analysis of tissue samples.

Trial Locations (1)

3103

Vestfold Hospital Trust, Tønsberg

All Listed Sponsors
collaborator

Oslo University Hospital

OTHER

lead

Janna Berg

OTHER